TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Pediatric Development Clinic Study: the Development, Medical and Nutritional Outcomes of Children Discharged From the Neonatal Unit in Rural Rwanda
Brief Summary: Many preterm, low birth weight and other high-risk infants are surviving the early neonatal period. However, upon discharge from the neonatal units, this at-risk population has little support for their health, nutrition and development in the community. To address this emerging need, Partners In Health in collaboration with the Ministry of Health and UNICEF, has created a pediatric developmental clinic (PDC) to follow the high-risk infants after discharge from hospitals and health centers.


Options:
A: Arm Label: Height measurement poster; Type: EXPERIMENTAL; Interventions: Behavioral: Height measurement poster | Arm Label: Community-based monitoring; Type: EXPERIMENTAL; Interventions: Behavioral: Community-based monitoring | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Height measurement poster; Assigned to Arm(s): Height measurement poster | Intervention Type: BEHAVIORAL; Name: Community-based monitoring; Assigned to Arm(s): Community-based monitoring
B: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Nutrition program developed using positive deviance approach | Arm Label: Comparison group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Nutrition program developed using positive deviance approach; Assigned to Arm(s): Intervention group
C: Intervention Type: OTHER; Name: Pediatric Development Clinic (PDC); Assigned to Arm(s): N/A
D: Arm Label: Training Plus; Type: EXPERIMENTAL; Interventions: Behavioral: Training Plus | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: No Inputs then Community development and training | Arm Label: Training Only; Type: EXPERIMENTAL; Interventions: Behavioral: Training Only | Intervention Type: BEHAVIORAL; Name: Training Plus; Assigned to Arm(s): Training Plus | Intervention Type: BEHAVIORAL; Name: Training Only; Assigned to Arm(s): Training Only | Intervention Type: BEHAVIORAL; Name: No Inputs then Community development and training; Assigned to Arm(s): Control

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of the iMBC/ECD Model on Maternal Mental Health and Child Development in Ghana
Brief Summary: The Duke research team will work with Catholic Relief Services (CRS) and lead the design and implementation of a cluster-randomized trial in Northern Ghana to assess the impact of the Integrated Mothers and Babies Course \& Early Childhood Development (iMBC/ECD) intervention on the mental wellbeing of mothers of children under 2 and their children's attainment of age-appropriate developmental milestones.


Options:
A: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: APP-based case management service, Behavioral: Standard-of-care followup service | Arm Label: control group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard-of-care followup service | Intervention Type: BEHAVIORAL; Name: APP-based case management service; Assigned to Arm(s): Intervention group | Intervention Type: BEHAVIORAL; Name: Standard-of-care followup service; Assigned to Arm(s): Intervention group, control group
B: Arm Label: Self Help Plus; Type: EXPERIMENTAL; Interventions: Behavioral: Self Help Plus | Arm Label: Enhanced Treatment As Usual; Type: OTHER; Interventions: Other: Enhanced Treatment As Usual | Intervention Type: BEHAVIORAL; Name: Self Help Plus; Assigned to Arm(s): Self Help Plus | Intervention Type: OTHER; Name: Enhanced Treatment As Usual; Assigned to Arm(s): Enhanced Treatment As Usual
C: Arm Label: Intervention (iMBC/ECD + C-PrES); Type: EXPERIMENTAL; Interventions: Behavioral: Integrated Mothers and Babies Course | Arm Label: Control (C-PrES); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Integrated Mothers and Babies Course; Assigned to Arm(s): Intervention (iMBC/ECD + C-PrES)
D: Arm Label: THPP-I; Type: EXPERIMENTAL; Interventions: Behavioral: THPP-I, Behavioral: EUC | Arm Label: Enhanced usual care (EUC); Type: OTHER; Interventions: Behavioral: EUC | Intervention Type: BEHAVIORAL; Name: THPP-I; Assigned to Arm(s): THPP-I | Intervention Type: BEHAVIORAL; Name: EUC; Assigned to Arm(s): Enhanced usual care (EUC), THPP-I

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: THE PEBBLES STUDY: A Randomised Controlled Trial to Prevent Eczema, Food Allergy and Sensitisation Using a Skin Barrier Improvement Strategy
Brief Summary: This is a phase III, single blind (outcome assessor is blinded), randomised controlled multicentre trial of the effect of EpiCeram emollient for improving and maintaining skin barrier function and reducing incidence of eczema and food allergy in high risk infants.

A total of 760 participants with a first degree family history of allergic disease (asthma, eczema, allergic rhinitis or food allergy) will be recruited (380 each group) from maternity wards of three hospitals.


Options:
A: Arm Label: Balneum oil bath; Type: EXPERIMENTAL; Interventions: Other: Balneum oil bath | Arm Label: standard skin cleanser; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Balneum oil bath; Assigned to Arm(s): Balneum oil bath
B: Arm Label: Topical Emollient; Type: EXPERIMENTAL; Interventions: Other: Topical Emollient | Arm Label: Routine Skin Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Topical Emollient; Assigned to Arm(s): Topical Emollient
C: Arm Label: Daily Emollient; Type: EXPERIMENTAL; Interventions: Other: Participant choice of over-the-counter emollients: Vaseline, Vanicream, CeraVe Healing Ointment, CeraVe cream, Cetaphil cream | Arm Label: Natural Skin; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Participant choice of over-the-counter emollients: Vaseline, Vanicream, CeraVe Healing Ointment, CeraVe cream, Cetaphil cream; Assigned to Arm(s): Daily Emollient
D: Arm Label: Twice daily use treatment with EpiCeram; Type: ACTIVE_COMPARATOR; Interventions: Drug: EpiCeram | Arm Label: Standard skin care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: EpiCeram; Assigned to Arm(s): Twice daily use treatment with EpiCeram

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: THE PEBBLES STUDY: A Randomised Controlled Trial to Prevent Eczema, Food Allergy and Sensitisation Using a Skin Barrier Improvement Strategy
Brief Summary: This is a phase III, single blind (outcome assessor is blinded), randomised controlled multicentre trial of the effect of EpiCeram emollient for improving and maintaining skin barrier function and reducing incidence of eczema and food allergy in high risk infants.

A total of 760 participants with a first degree family history of allergic disease (asthma, eczema, allergic rhinitis or food allergy) will be recruited (380 each group) from maternity wards of three hospitals.


Options:
A: Arm Label: Observation only; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Food intervention; Type: EXPERIMENTAL; Interventions: Other: Food intervention | Arm Label: Skin care; Type: EXPERIMENTAL; Interventions: Other: Skin care | Arm Label: Food intervention and skin care; Type: EXPERIMENTAL; Interventions: Other: Food intervention, Other: Skin care | Intervention Type: OTHER; Name: Food intervention; Assigned to Arm(s): Food intervention, Food intervention and skin care | Intervention Type: OTHER; Name: Skin care; Assigned to Arm(s): Food intervention and skin care, Skin care
B: Arm Label: Twice daily use treatment with EpiCeram; Type: ACTIVE_COMPARATOR; Interventions: Drug: EpiCeram | Arm Label: Standard skin care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: EpiCeram; Assigned to Arm(s): Twice daily use treatment with EpiCeram
C: Arm Label: Peanut Consumption Group; Type: EXPERIMENTAL; Interventions: Biological: Peanut Consumption Group | Arm Label: Peanut Avoidance Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BIOLOGICAL; Name: Peanut Consumption Group; Assigned to Arm(s): Peanut Consumption Group
D: Arm Label: Topical Emollient; Type: EXPERIMENTAL; Interventions: Other: Topical Emollient | Arm Label: Routine Skin Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Topical Emollient; Assigned to Arm(s): Topical Emollient

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Mindfulness for Students
Brief Summary: The aim of the study is to find out, weather the students' wellbeing and functional ability can be enhanced by two different type of mindfulness interventions: 1) face-to-face group-based training, and 2) internet-based training based in mindfulness and acceptance and commitment therapy. Study results may be used to decide whether it is worth offering mindfulness training for medical faculty students, and what kind of training would be most suitable and effective in the medical education context.


Options:
A: Arm Label: CORE condition; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy | Arm Label: Healthy lifestyle; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Healthy lifestyle | Arm Label: Waiting List Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): CORE condition | Intervention Type: BEHAVIORAL; Name: Healthy lifestyle; Assigned to Arm(s): Healthy lifestyle
B: Arm Label: Face-to-face group-based mindfulness; Type: EXPERIMENTAL; Interventions: Behavioral: Face-to-face group-based mindfulness | Arm Label: Internet-based mindfulness; Type: EXPERIMENTAL; Interventions: Behavioral: Internet-based mindfulness | Arm Label: Waiting-list control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Face-to-face group-based mindfulness; Assigned to Arm(s): Face-to-face group-based mindfulness | Intervention Type: BEHAVIORAL; Name: Internet-based mindfulness; Assigned to Arm(s): Internet-based mindfulness
C: Arm Label: Group therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Manualized Therapy | Arm Label: Control Group; Type: OTHER; Interventions: Behavioral: Control Group | Intervention Type: BEHAVIORAL; Name: Manualized Therapy; Assigned to Arm(s): Group therapy | Intervention Type: BEHAVIORAL; Name: Control Group; Assigned to Arm(s): Control Group
D: Arm Label: Facilitated small group; Type: EXPERIMENTAL; Interventions: Behavioral: Facilitated small groups | Arm Label: Unstructured protected time; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Unstructured time. | Arm Label: Usual practice; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Usual practice | Intervention Type: BEHAVIORAL; Name: Facilitated small groups; Assigned to Arm(s): Facilitated small group | Intervention Type: BEHAVIORAL; Name: Unstructured time.; Assigned to Arm(s): Unstructured protected time | Intervention Type: BEHAVIORAL; Name: Usual practice; Assigned to Arm(s): Usual practice

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pentaerithrityltetranitrat (PETN) Zur Sekundärprophylaxe Der Intrauterinen Wachstumsretardierung
Brief Summary: Approximately 10% of all pregnancies experience mal perfusion of the placenta resulting in fetal growth restriction (FGR) of the fetus. FGR is the most important cause of perinatal mortality and morbidity. Impaired placental function determined by insufficient transformation of the uterine arteries and mal-perfusion of the placenta is the leading cause of FGR. So far, there is no treatment option for pregnancies complicated by FGR and the clinical management is restricted to close monitoring, assessing for the optimal time point of delivery of the fetus threatened by intrauterine death. In a pilot study a risk reduction of 38% for the development of severe FGR and FGR or death could be demonstrated by giving the organic nitrate pentaerithrityl-tetranitrate (PETN) to patients recognized at risk for FGR by impaired uterine artery Doppler at mid gestation (Schleussner, 2014). To confirm these results this prospective randomized placebo controlled double-blinded multicentre trial, was initiated.


Options:
A: Arm Label: Sildenafil; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sildenafil | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Sildenafil; Assigned to Arm(s): Sildenafil | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Sildenafil; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sildenafil | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Sildenafil; Assigned to Arm(s): Sildenafil | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: L ARG | Arm Label: B; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: L ARG; Assigned to Arm(s): A | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): B
D: Arm Label: Placebos; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebos | Arm Label: Pentalong; Type: ACTIVE_COMPARATOR; Interventions: Drug: Pentalong | Intervention Type: DRUG; Name: Pentalong; Assigned to Arm(s): Pentalong | Intervention Type: DRUG; Name: Placebos; Assigned to Arm(s): Placebos

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Involving Clinical Pharmacists in Transitional Care to Reduce Drug-related Readmissions Among the Elderly - a Randomized Controlled Trial
Brief Summary: This randomized controlled trial primarily investigates if a clinical pharmacist intervention can reduce drug-related readmissions among patients \>75 years. The intervention targets the transfer between hospital and primary care. In brief, the intervention includes medical chart reviews and patient interviews during a period of 180 days.


Options:
A: Arm Label: Pharmacist Arm; Type: EXPERIMENTAL; Interventions: Behavioral: Pharmacist-led Hospital Discharge Care Intervention | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Pharmacist-led Hospital Discharge Care Intervention; Assigned to Arm(s): Pharmacist Arm
B: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Other: Enhanced clinical pharmacist service | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Enhanced clinical pharmacist service; Assigned to Arm(s): Intervention group
C: Arm Label: Patients without intervention; Type: ACTIVE_COMPARATOR; Interventions: Other: Clinical pharmacy model | Arm Label: Patients with intervention; Type: EXPERIMENTAL; Interventions: Other: Clinical pharmacy model | Intervention Type: OTHER; Name: Clinical pharmacy model; Assigned to Arm(s): Patients with intervention, Patients without intervention
D: Arm Label: Patient Navigator; Type: EXPERIMENTAL; Interventions: Other: Patient Navigator, Other: Usual care | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Patient Navigator; Assigned to Arm(s): Patient Navigator | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): Patient Navigator

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An Open-label Randomized-Controlled Trial of Early Screening Test for Pre-eclampsia and Growth Restriction
Brief Summary: A study of aspirin use in pregnancy to prevent high blood pressure and growth restriction of the fetus


Options:
A: Arm Label: Non-intervention group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Other: Low-dose aspirin in women with high risk of preeclampsia | Intervention Type: OTHER; Name: Low-dose aspirin in women with high risk of preeclampsia; Assigned to Arm(s): Intervention group
B: Arm Label: Routine low-dose aspirin; Type: EXPERIMENTAL; Interventions: Drug: Low dose aspirin | Arm Label: No aspirin; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Test-indicated low-dose aspirin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Low dose aspirin | Intervention Type: DRUG; Name: Low dose aspirin; Assigned to Arm(s): Routine low-dose aspirin, Test-indicated low-dose aspirin
C: Arm Label: aspirin; Type: EXPERIMENTAL; Interventions: Drug: Aspirin | Arm Label: blank; Type: OTHER; Interventions: Other: Blank | Intervention Type: DRUG; Name: Aspirin; Assigned to Arm(s): aspirin | Intervention Type: OTHER; Name: Blank; Assigned to Arm(s): blank
D: Arm Label: Aspirin; Type: EXPERIMENTAL; Interventions: Drug: Aspirin | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: Aspirin; Assigned to Arm(s): Aspirin | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): placebo

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Low-Carbohydrate Dietary Pattern on Glycemic Outcomes Trial
Brief Summary: The proposed randomized controlled trial will test the effect of a low-carbohydrate diet on hemoglobin A1c among individuals with elevated hemoglobin A1c that are within the range of prediabetes or diabetes. Results may provide evidence about the role of carbohydrate restriction in individuals with or at high risk of type 2 diabetes.


Options:
A: Arm Label: CRHP Diet; Type: EXPERIMENTAL; Interventions: Dietary Supplement: CRHP Diet | Arm Label: CD Diet; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: CD Diet | Intervention Type: DIETARY_SUPPLEMENT; Name: CRHP Diet; Assigned to Arm(s): CRHP Diet | Intervention Type: DIETARY_SUPPLEMENT; Name: CD Diet; Assigned to Arm(s): CD Diet
B: Arm Label: Low-carbohydrate diet; Type: EXPERIMENTAL; Interventions: Behavioral: low-carbohydrate diet | Arm Label: Low-fat diet; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: low-fat diet | Intervention Type: BEHAVIORAL; Name: low-carbohydrate diet; Assigned to Arm(s): Low-carbohydrate diet | Intervention Type: BEHAVIORAL; Name: low-fat diet; Assigned to Arm(s): Low-fat diet
C: Arm Label: Low-Carbohydrate Diet; Type: EXPERIMENTAL; Interventions: Behavioral: Low-Carbohydrate Diet | Arm Label: Usual Diet; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Low-Carbohydrate Diet; Assigned to Arm(s): Low-Carbohydrate Diet
D: Arm Label: Low-Carb High-Fat Breakfast; Type: EXPERIMENTAL; Interventions: Other: Low-Carb High-Fat breakfast | Arm Label: Low fat "Standard Care" Control Breakfast; Type: ACTIVE_COMPARATOR; Interventions: Other: Low fat "standard care" control breakfast | Intervention Type: OTHER; Name: Low-Carb High-Fat breakfast; Assigned to Arm(s): Low-Carb High-Fat Breakfast | Intervention Type: OTHER; Name: Low fat "standard care" control breakfast; Assigned to Arm(s): Low fat "Standard Care" Control Breakfast

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Music to Improve Sleep Quality in Adults With Depression and Insomnia: a Randomized Controlled Trial Using Mixed Methods
Brief Summary: Insomnia is a common sleep disorder for patients with depression. This has a major impact on the quality of life for the individual.

The aim is to investigate, whether music intervention is effective in

1. improving sleep quality,
2. reducing symptoms of depression and
3. improving quality of life

Participants use a sound pillow and selected music in the The Music Star app at home as a sleep aid in 4 weeks.


Options:
A: Arm Label: Experimental Group; Type: EXPERIMENTAL; Interventions: Other: Music Intervention | Arm Label: Waitlist Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Music Intervention; Assigned to Arm(s): Experimental Group
B: Arm Label: Clinical Improvisation Instrumental Music Therapy; Type: EXPERIMENTAL; Interventions: Other: Clinical Improvisation Instrumental Music Therapy | Arm Label: Clinical Vocal Improvisation; Type: EXPERIMENTAL; Interventions: Other: Clinical Vocal Improvisation | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Clinical Improvisation Instrumental Music Therapy; Assigned to Arm(s): Clinical Improvisation Instrumental Music Therapy | Intervention Type: OTHER; Name: Clinical Vocal Improvisation; Assigned to Arm(s): Clinical Vocal Improvisation
C: Arm Label: Music Group; Type: EXPERIMENTAL; Interventions: Behavioral: Guided Imagery and Music | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Guided Imagery and Music; Assigned to Arm(s): Music Group
D: Arm Label: Experimental: Tailored Music; Type: EXPERIMENTAL; Interventions: Behavioral: Tailored music listening intervention | Arm Label: 4-week Wait-list control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Tailored music listening intervention; Assigned to Arm(s): Experimental: Tailored Music

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Short-term Versus Long-term Mentalization-based Therapy for Outpatients With Subthreshold or Diagnosed Borderline Personality Disorder: a Randomized Clinical Trial
Brief Summary: The study will evaluate the benefitial and harmful effects of short-term (20 weeks) compared to long-term (14 months) mentalization-based therapy for outpatients with subthreshold or diagnosed borderline personality disorder.


Options:
A: Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Risperidone | Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Risperidone | Intervention Type: DRUG; Name: Risperidone; Assigned to Arm(s): 1, 2
B: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Rexulti; Type: EXPERIMENTAL; Interventions: Drug: Rexulti | Intervention Type: DRUG; Name: Rexulti; Assigned to Arm(s): Rexulti | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: active anodal tDCS to ventrolateral prefrontal cortex (VLPFC); Type: ACTIVE_COMPARATOR; Interventions: Device: Transcranial direct current stimulation | Arm Label: sham anodal tDCS to VLPFC; Type: SHAM_COMPARATOR; Interventions: Device: Transcranial direct current stimulation | Arm Label: Discontinued prior to randomization; Type: OTHER; Interventions: Other: No intervention | Intervention Type: DEVICE; Name: Transcranial direct current stimulation; Assigned to Arm(s): active anodal tDCS to ventrolateral prefrontal cortex (VLPFC), sham anodal tDCS to VLPFC | Intervention Type: OTHER; Name: No intervention; Assigned to Arm(s): Discontinued prior to randomization
D: Arm Label: Short-term MBT; Type: EXPERIMENTAL; Interventions: Other: Short-term MBT | Arm Label: Long-term MBT; Type: ACTIVE_COMPARATOR; Interventions: Other: Long-term MBT | Intervention Type: OTHER; Name: Short-term MBT; Assigned to Arm(s): Short-term MBT | Intervention Type: OTHER; Name: Long-term MBT; Assigned to Arm(s): Long-term MBT

Answer: D